Cocrystal Pharma, Inc. (NASDAQ:COCP) is Worth a Shot if You're a Risk-Capital Investor

Retrieved on: 2021-03-08 15:56:15

Tags for this article:

Financial markets

Finance

Initial public offering

Cocrystal Pharma Inc

Click the tags to see associated articles and topics

Cocrystal Pharma, Inc. (NASDAQ:COCP) is Worth a Shot if You're a Risk-Capital Investor. View article details on hiswai:

Excerpt

There are 28 institutions holding the Cocrystal Pharma, Inc. stock share, with Renaissance Technologies, LLC the top institutional holder. As of Dec 30 ...

Article found on: marketingsentinel.com

View Original Article